Sergei is passionate about the enormous potential of applying AI to rational drug design with an ultimate goal of advancing human health. Sergei has a rich technical background with over 20 years experience in scientific research, engineering, machine learning, and product management applied to healthcare and life science.

Before joining Isomorphic Labs, Sergei was Senior Vice President and Chief Technology Officer at SOPHiA GENETICS, where he helped develop and run an AI-based molecular diagnostics and data-driven medicine platform operating in more than 70 countries.
Sergei has held senior roles at Amazon.com, where he launched the first Canadian software engineering centre; at BPS Inc., where he developed a best-in-class Governance, Risk, and Compliance platform; at the Ontario Institute for Cancer Research, where he led the Technical Working Group of the Pan Cancer Analysis of Whole Genomes Project, the world’s largest cancer data analysis initiative; and at EMBL where he developed a cloud-based scientific workflow framework.

Sergei has a degree in computer science and mathematics from the University of Toronto and a PhD in computer science from Heidelberg University, where he developed novel distributed algorithms for analysing cancer genomes.